GlucoTrack, Inc. (NASDAQ:GCTK – Get Free Report) saw a large growth in short interest in the month of August. As of August 31st, there was short interest totalling 16,200 shares, a growth of 36.1% from the August 15th total of 11,900 shares. Approximately 0.6% of the company’s stock are sold short. Based on an average trading volume of 15,400 shares, the short-interest ratio is presently 1.1 days.
GlucoTrack Stock Down 0.3 %
Shares of GlucoTrack stock traded down $0.01 during trading on Monday, reaching $2.90. 9,897 shares of the company traded hands, compared to its average volume of 28,133. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.12 and a quick ratio of 0.12. GlucoTrack has a 1-year low of $0.66 and a 1-year high of $4.95. The company has a 50 day moving average price of $1.93 and a 200-day moving average price of $2.13. The firm has a market capitalization of $15.89 million, a PE ratio of -1.42 and a beta of 0.13.
GlucoTrack (NASDAQ:GCTK – Get Free Report) last announced its quarterly earnings results on Tuesday, August 13th. The company reported ($0.82) EPS for the quarter.
GlucoTrack Company Profile
GlucoTrack, Inc, a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain.
Further Reading
- Five stocks we like better than GlucoTrack
- Stock Market Sectors: What Are They and How Many Are There?
- Palo Alto Analysts Drive it to New Highs: 50% Upside Is Possible
- Canada Bond Market Holiday: How to Invest and Trade
- Roblox’s Growth Beyond Kids: Stock Set for Major Moves
- What Are Dividend Champions? How to Invest in the Champions
- 5 Oversold Stocks to Buy Right Now
Receive News & Ratings for GlucoTrack Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlucoTrack and related companies with MarketBeat.com's FREE daily email newsletter.